ClearOne is trading 8.2% up today at $10.99 as the stock continues to react to its recently announced reverse merger with Cortigent.
- The transformative deal involves a merger with Cortigent, a subsidiary of Vivani Medical, and a concurrent $10–$15 million financing round.
- Shares have experienced extreme volatility since the July 1–2, 2026 announcement, which triggered a sharp repricing and ongoing speculative trading.